Recently we purified and identified a previously uncharacterized transcription factor from rat liver binding to the carbohydrate responsive element of the L-type pyruvate kinase (L-PK) gene. This factor was named carbohydrate responsive element binding protein (ChREBP). ChREBP, essential for L-PK gene transcription, is activated by high glucose and inhibited by cAMP. Here, we demonstrated that (i) nuclear localization signal and basic helix-loop-helix͞leucine-zipper domains of ChREBP were essential for the transcription, and (ii) these domains were the targets of regulation by cAMP and glucose. Among three cAMP-dependent protein kinase phosphorylation sites, Ser 196 and Thr 666 were the target sites. Phosphorylation of the former resulted in inactivation of nuclear import, and that of the latter resulted in loss of the DNA-binding activity and L-PK transcription. On the other hand, glucose activated the nuclear import by dephosphorylation of Ser 196 in the cytoplasm and also stimulated the DNAbinding activity by dephosphorylation of Thr 666 in the nucleus. These results thus reveal mechanisms for regulation of ChREBP and the L-PK transcription by excess carbohydrate and cAMP. T he liver is the principal organ responsible for conversion of excess dietary carbohydrate to triglycerides. A high carbohydrate diet leads to activation of several regulatory enzymes of glycolysis and lipogenesis including L-type pyruvate kinase (L-PK), acetyl CoA carboxylase, and fatty acid synthase (1). Excess carbohydrate also results in post-translational activation of several key enzymes involved in carbohydrate metabolism and lipogenesis (1). Until recently it was thought that hormones such as insulin and glucagon regulate the transcription of genes. It has only been appreciated recently that nutrients themselves play an important role in the regulation.
T
he liver is the principal organ responsible for conversion of excess dietary carbohydrate to triglycerides. A high carbohydrate diet leads to activation of several regulatory enzymes of glycolysis and lipogenesis including L-type pyruvate kinase (L-PK), acetyl CoA carboxylase, and fatty acid synthase (1) . Excess carbohydrate also results in post-translational activation of several key enzymes involved in carbohydrate metabolism and lipogenesis (1) . Until recently it was thought that hormones such as insulin and glucagon regulate the transcription of genes. It has only been appreciated recently that nutrients themselves play an important role in the regulation.
Glucose-stimulated L-PK gene expression in liver is mediated through the glucose or carbohydrate response element (ChRE) that is located in the region Ϫ183 to Ϫ96 base pairs upstream from the cap site of the L-PK gene (2) . The binding site for the ChRE contains an E-box sequence, CACGGG, separated by 5 bases that corresponds to the consensus binding site (CACGTG) for upstream stimulatory factors and their related family members. Several transcription factors binding the ChRE have been reported previously (3) (4) (5) , but none of these factors vary with diet, and the mechanisms of regulation are still unclear.
We recently purified, identified, and cloned a transcription factor that binds specifically to the ChRE of the L-PK gene (6) . We termed this new transcription factor ChRE-binding protein (ChREBP; ref. 6) . ChREBP is expressed specifically in liver and is responsive to excess carbohydrate, i.e., ChREBP is activated by high glucose diet and inhibited by high fat diet. Overexpression of ChREBP in primary cultured hepatocytes results in increased transcription activity of the L-PK gene in response to high glucose.
ChREBP is a member of the basic helix-loop-helix͞leucine zipper (bHLH͞ZIP) family of transcription factors of M r ϭ 94,600 and contains several potentially functional domains including a nuclear localization signal (NLS), a proline-rich stretch (PRO), a bHLH͞ZIP, and a ZIP-like domain ( Fig. 1; ref. 6 ). It contains three consensus phosphorylation sites for PKA. Previously we demonstrated that a partially purified ChREBP from rat liver nuclei is phosphorylated by PKA in vitro resulting in loss of the DNAbinding activity (6) , but the site of the phosphorylation and mechanisms of loss of the DNA-binding activity are not known.
The objectives of the current investigation were to characterize ChREBP further by identifying the functional domains and to determine the phosphorylation sites, regulated negatively by cAMP and PKA and positively by high glucose.
Experimental Procedures
Materials. All reagents were from Sigma unless otherwise indicated.
Plasmids, Domain Deletion, and Mutagenesis. The constructs were verified by nucleotide sequencing. Full-length wild-type (WT) ChREBP cDNA (GenBank accession no. AF156604) was ligated into the Invitrogen mammalian expression vector pcDNA3 (ChREBP͞pcDNA3; ref. 6) or CLONTECH vector pEGFP-N3 (ChREBP͞pEGFP) encoding enhanced green fluorescent protein (GFP). The promoter region between positions Ϫ206 and Ϫ7 of the L-PK gene was ligated into the luciferase expression plasmid, pGL-3 basic vector (Promega), as described previously (7) . Plasmids containing the NLS, PRO, bHLH͞ZIP, ZIP-like deletion mutants, or point mutants in the putative phosphorylation sites of PKA of ChREBP were constructed by using the QuickChange site-directed mutagenesis kit (Stratagene). Oligonucleotides used to introduce a new restriction site immediately upstream or downstream of each domain are listed in Table 1 . Oligonucleotides used to introduce the desired mutations are listed in Table 2 . The double mutant plasmids were constructed by using the same method as that used for making single mutants.
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Treatment of Rats with Dibutyryl (db)-cAMP and Nuclear Extract
Preparation. Male Sprague-Dawley rats weighting 250 g were used in all experiments. After 48 h of starvation, the rats were fed a high carbohydrate diet, and db-cAMP (1 mmol͞kg) was injected intraperitoneally. The rats were killed 10 and 30 min after injection, and nuclear extracts were prepared immediately from rat liver as described previously (6) .
Primary Hepatocyte Culture, Transfection, Luciferase Activity Assay, and DNA Binding Assay. The primary hepatocyte culture, transfection, luciferase activity assay, and DNA binding assay were performed as described previously (6) . Each GFP-ChREBP mutant expressed equally (transfected hepatocytes ϭ Ϸ10% of 1 ϫ 10 6 hepatocytes).
Protein Kinase and Protein Phosphatase Inhibitors. Before exchange to 5.5 or 27.5 mM glucose medium, transfected primary culture hepatocytes were treated for 1 h with 10 M H-89, 500 nM cantharidic acid (Calbiochem), 5 M KN-62 (Calbiochem), 30 M PD98059 (Calbiochem), 50 M Genistein, or dimethyl sulfoxide vehicle.
Determination of Subcellular Localization of ChREBP. Subcellular localization of GFP-fused WT ChREBP or its mutants was determined by using a confocal laser scanning microscope (Bio-Rad). To quantitate nuclear localization of ChREBP for each condition, 100 transfected hepatocytes from five independent experiments were scored in a blinded fashion as to whether the GFP-fused ChREBP was predominantly nuclear or cytoplasmic. The identity of the nucleus was verified by comparative phase-contrast microscopy. , and the reaction mixture was incubated at 30°C. At given time intervals, aliquots were removed and DNA-binding activity was determined by a gel shift assay (6) . [ 32 P]Phosphate-bound ChREBP was also determined as described previously (8) .
Statistical Analysis. All data were expressed as mean Ϯ SEM. The differences between two groups were analyzed by using the MannWhitney u test. A P value less than 0.05 was considered statistically significant.
Results

Effects of Domain Deletion of ChREBP on Transcriptional Activity of the L-PK Gene.
To determine the function of each domain of ChREBP ( Fig. 1) , various domain deletion mutants of ChREBP were prepared. The effects of these mutant ChREBPs on L-PK The mutated nucleotides are underlined.
transcription activity were determined with a dual luciferase reporter system. Primary cultured hepatocytes were transfected with the WT and mutant ChREBPs, and the cells were maintained in low (5.5 mM) and high (27.5 mM) glucose. As shown in Fig. 2 , the transcriptional activities in the cells transfected with empty vector were caused by the endogenous activity of ChREBP in the primary hepatocytes. The WT ChREBP showed at least 2-fold activation of the activity in high glucose compared with that in the empty vector. To confirm that this increase was caused by glucose metabolism and not osmotic stress, primary hepatocytes were incubated with 500 mM NaCl instead of 27.5 mM glucose. The increase in transcriptional activity was not seen in NaCl, and the transcriptional activation required high glucose. Among the mutant ChREBPs, deletion of NLS or the bHLH͞ ZIP domain resulted in complete loss of the high glucose-induced transcriptional activation. However, the deletion of PRO or the ZIP-like domain at the C terminus did not affect the transcriptional activity. These results demonstrated that the NLS and bHLH͞ZIP domains were essential for its glucose response, but the PRO and the ZIP-like domains were not involved in the high glucose-induced transcriptional activation of the L-PK gene.
Effects of Various Inhibitors of Protein Kinase and Phosphatase on
ChREBP-Induced Transcriptional Activation of the L-PK Gene. Protein phosphorylation and dephosphorylation is one way to regulate the activity of a transcription factor. To investigate possible involvement of phosphorylation and dephosphorylation of ChREBP in the glucose-induced activation of L-PK gene transcription, we examined the effect of a number of different inhibitors of various protein kinases and protein phosphatases. The addition of H-89, a specific inhibitor of PKA, to the culture medium increased the transcriptional activity in the ChREBP-overexpressed hepatocytes under both low and high glucose (Fig. 3) . H-89 also stimulated endogenous ChREBP, but the effect was small. On the other hand, cantharidic acid, a specific inhibitor of PP2A, inhibited transcriptional activity of the L-PK gene in both 5.5 and 27.5 mM glucose. KN-62, PD98059, and Genistein, which are specific inhibitors of calcium͞calmodulin-dependent protein kinase II, mitogenactivated protein kinase, and tyrosine kinase, respectively, did not affect transcriptional activity of the L-PK gene, suggesting that these protein kinases were not involved in the regulation of ChREBP. These results suggested that ChREBP activity was inhibited by phosphorylation catalyzed by PKA, and the activity was regained by PP2A.
Effects of H-89 and Cantharidic Acid on Subcellular Localization of
ChREBP. NLS domains serve as signals for import of transcription factors into nuclei. We constructed a GFP-fused WT ChREBP as well as a series of domain deletion mutants of ChREBP, transfected the constructs into primary cultured hepatocytes, and observed subcellular localization of ChREBP with confocal laser scanning microscopy. Fig. 4 shows representative images of subcellular localization of ChREBP under low or high glucose. Nontransfected hepatocytes did not show any fluorescence (Fig. 4A) , and endogenous ChREBP could not be seen under these conditions. Empty vector-transfected hepatocytes showed weak diffused fluorescence throughout the cells (Fig. 4B) . The ChREBP-transfected hepatocytes showed cytoplasmic ( Fig. 4C ) and nuclear localization ( Fig.   Fig. 2 . Effects of domain deletion of ChREBP on transcription activity of the L-PK gene. Rat primary cultured hepatocytes were transfected with the WT ChREBP or a series of domain deletion mutants. A pGL3 basic plasmid (simian virus 40 promoter driving firefly luciferase gene), carrying the promoter region between positions Ϫ206 and Ϫ7 of the L-PK gene, and pRL-TK (thymidine kinase promoter driving the Renilla luciferase gene) were also transfected into each cell as a reporter gene and an internal control, respectively. After transfection, cells were incubated under 5.5 mM (ᮀ) or 27.5 mM (s) glucose for 12 h. Relative luciferase activity was calculated as described in Experimental Procedures and are expressed as mean Ϯ SEM (n ϭ 5). * , P Ͻ 0.05 compared with that of WT ChREBP. 4D) in low and high glucose, respectively. The nuclei import was complete in 8 h, whereas the L-PK promoter activity took 20 h. Thus, the rate of the translocation of ChREBP was rapid enough to activate L-PK gene expression.
The WT ChREBP showed Ϸ40 and 80% of nuclear staining rate in 5.5 and 27.5 mM glucose, respectively (Fig. 5A) . NLS-deleted ChREBP mutant showed less than 10% of nuclear staining rate in both 5.5 and 27.5 mM glucose. These results demonstrated that high glucose stimulated the translocation of ChREBP from cytosol into nuclei. By treatment of hepatocytes with H-89, the nuclear staining rate was increased in 5.5 mM glucose. On the other hand, cantharidic acid significantly decreased the nuclear staining rate, suggesting that the dephospho form of ChREBP but not the phospho form was translocated into the nuclei (Fig. 5A) . Thus, NLS domain was required for nuclear translocation, and the nuclear translocation of ChREBP was regulated negatively by PKAcatalyzed phosphorylation and positively by dephosphorylation by PP2A.
Effects of Mutation of Ser 196 on Subcellular Localization of ChREBP.
To determine the phosphorylation sites of ChREBP, which regulate Rat primary cultured hepatocytes were transfected with GFP-fused WT ChREBP, S196A, or S196D, and the cells were incubated in 5.5 mM (ᮀ) or 27.5 mM (s) glucose for 12 h. For each condition, 100 transfected hepatocytes from four independent experiments were scored in a blinded fashion as to whether the GFP-fused ChREBP was predominantly nuclear or cytoplasmic as described in Experimental Procedures. The values are expressed as mean Ϯ SEM. * , P Ͻ 0.05 compared with that of WT ChREBP. Fig. 6 . Effect of db-cAMP on the DNAbinding activity of ChREBP in vivo. Rats were fed high carbohydrate diets after 48 h of starvation, and db-cAMP (60 mg͞kg) was injected intraperitoneally. The rats were killed 10 and 30 min after the injection, and the DNA-binding activity of ChREBP was examined by using a gel shift assay. USF, upstream stimulatory factor. the nuclear import, we mutated all three consensus PKA phosphorylation sites. Because a putative PKA phosphorylation site (Ser 196 designated as P1 in Fig. 1 ) occurs near the NLS domain, we prepared Ala and Asp mutants of ChREBP (S196A and S196D; Fig. 5B ) and determined the effect on nuclear localization. S196A showed Ϸ90% of nuclear staining rate in both 5.5 and 27.5 mM glucose (Fig. 5C ), whereas the S196D mutant showed less than 10% of nuclear staining rate (Fig. 5C) . To investigate the effects of phosphorylation states of the other PKA phosphorylation sites, we constructed double mutants (S196A ϩ S626A, S196A ϩ S626D, S196A ϩ T666A, and S196A ϩ T666D; Fig. 5B ). All these double mutants showed Ϸ90% of nuclear staining rate, suggesting strongly that the nuclear translocation was regulated by phosphorylation at Ser 196 regardless of the phosphorylation states of the other sites.
Effect of db-cAMP on the DNA-Binding Activity of ChREBP in Vivo. To determine the effect of cAMP on the DNA-binding activity of ChREBP in vivo, rats were treated with i.p. injections of db-cAMP. Nuclear extracts of db-cAMP-treated rat livers were assayed for DNA-binding activity. The DNA-binding activity was inactivated readily within 10 min after the db-cAMP injection (Fig. 6 ). Because these rats were fed, ChREBP was localized already in nuclei, and in our preliminary experiments using GFP-ChREBP, we showed that the ChREBP was not exported from nuclei to cytoplasm within 10 min after addition of db-cAMP into 27.5 mM glucose medium (n ϭ 3; data not shown). Moreover, it has been reported that nuclear export takes 30 min-2 h (9, 10). The loss of the DNAbinding activity may be caused by the inactivation of DNA binding, but we cannot exclude the possibility of export of ChREBP.
Effects of PKA and PP2A on the DNA-Binding Activity of ChREBP in Vitro. By using a recombinant C-terminal region of ChREBP containing the bHLH͞ZIP with a single phosphorylation site (Thr 666 , P3 in Fig. 1) , we determined the effect of PKA-dependent phosphorylation of Thr 666 on the DNA-binding activity of bHLH͞ ZIP domain. As shown in Fig. 7 , A and Inset, 32 P was incorporated into the bHLH͞ZIP domain; the DNA-binding activity was inactivated rapidly, and the rates of these changes were similar. The observation that both the phosphate incorporation and loss of the DNA-binding activity were similar suggested that the inactivation of DNA binding was a direct result of the phosphorylation at Thr 666 . Furthermore, PKA-dependent phosphorylation of the bHLH͞ZIP domain was fully reversible, because the incubation of the 32 Pphosphorylated bHLH͞ZIP domain with catalytic subunit of PP2A resulted in complete recovering of the activity (Fig. 7, B and Inset). , situated within the basic residues of the bHLH domain (designated as P2 and P3 in Fig. 1 ). To determine which phosphorylation site regulates the ChREBP DNA-binding activity, we constructed Ala and Asp mutants of these sites (S626A, S626D, T666A, and T666D). Both S626A and T666A mutants showed Ϸ2.5-fold activation of transcriptional activity by high glucose compared with that of WT ChREBP (Fig.  8A) . On the other hand, both S626D and T666D mutants showed much lower activity under both high and low glucose (Fig. 8A) . To exclude the effect of db-cAMP on nuclear translocation of ChREBP, double mutants (S196A ϩ S626A and S196A ϩ T666A) were constructed. Rat primary cultured hepatocytes were transfected with WT ChREBP, S196A ϩ S626A, or S196A ϩ T666A. After transfection, cells were incubated under 5.5 mM (ᮀ) or 27.5 mM (s) glucose, and cAMP was added to both low and high glucose. Relative luciferase activity was calculated as described in Experimental Procedures and are expressed as mean Ϯ SEM (n ϭ 5). * , P Ͻ 0.05 compared with that of WT ChREBP.
Fig. 9.
Schematic representation of possible regulatory mechanisms of ChREBP by glucose and cAMP in hepatocytes. Two PKA phosphorylation sites of ChREBP, Ser 196 (P1) and Thr 666 (P3), play crucial roles in high glucose-induced activation of ChREBP (P1 and P3 indicate the phosphorylated form at the sites). Glucose signaling may activate PP2A via a metabolite (X). In cytoplasm, Xactivated PP2A dephosphorylates P1 site of the ChREBP, which results in stimulation of import of ChREBP into the nucleus. Once ChREBP is localized in the nucleus, glucose activates the inactive form of ChREBP (P3-ChREBP) by dephosphorylation of the P3 site catalyzed by PP2A. ChREBP, which is dephosphorylated at P1 and P3 sites, binds to ChRE of the L-PK gene and consequently activates transcription of the L-PK gene. See Discussion.
